Jump to navigation

Home

Elsevier CME

Open menu
Cart
  • Log in
  • Register
  • Home
  • About
    • About
    • Partner With Us
  • Contact Us

You are here

Home » Where Are We Now? A Clinicians’ Guide to...

Where Are We Now? A Clinicians’ Guide to the Use of Follow-on Insulin for Patients with Diabetes

Course Video & Articles

  • Return to Course Home
Course Video & Articles

Click here to view the course video.

Click here to download a PDF of the webcast transcript

 

 

Click the below links for additional resources.

  • Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
  • Overcoming barriers to the initiation of insulin therapy
  • Biosimilar insulins
  • Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study
  • Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study)

Course outline

Course progress

  • Not started
    Pre-Activity Questions
    Open/Close details
    • Required
  • Not started
    Course Video & Articles
    Open/Close details
    • Required
  • Not started
    Post-Activity Test
    Open/Close details
    • Required
  • Not started
    Evaluation
    Open/Close details
    • Required
  • Not started
    Credit
    Open/Close details
    • Optional
  • Not started
    Certificate
    Open/Close details
    • Optional
Expand / Minimize

Course navigation

    Copyright © 2020 Elsevier Inc. All rights reserved. Privacy Policy. Terms and Conditions. Cookie Policy.  Cookie settings.
    Click here to visit the Elsevier CME website. Contact Us
    Hardware/Software Requirements

    This site is intended for health professionals.

    Powered by the EthosCE Learning Management System, a continuing education LMS.
        • Home
        • About
          • About
          • Partner With Us
        • Contact Us